Charles Baker-Glenn

This inventor holds 25 USPTO granted patents and 1 published patent application, plus 11 CIPO patents and 14 EPO patents. Top assignees: Chiesi Farmaceutici S.p.a., Genentech, Inc., Merck Serono S. a.. Active years: 2012-2018.

USPTO Granted Patents = 25 (Patent Applications = 1)

% Patents Active = 44.0

CIPO Patents = 11

EPO Patents = 14 (Patent Applications = 15)

Average Co-Inventor Count = 6.1

ph-index = 6

Forward Citations = 109(Granted Patents)

Location History:

Puckeridge, GB (2013)
St. Neots, GB (2014 - 2015)
Saffron Walden, IT (2016)
Essex, GB (2012 - 2018)
Saffron Walden, GB (2015 - 2018)

Company Filing History:

13 out of 341

Chiesi Farmaceutici S.p.a.

Years Active: 2012-2018

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10117860 - Aminoester derivatives (2018-11-06),

2. 10087176 - 3,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)--2-carbonyloxy)ethyl)pyridine derivatives as PDE-4 inhibitors (2018-10-02),

3. 9890151 - 3,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)- 2-carbonyloxy)ethyl)pyridine derivatives as PDE-4 inhibitors (2018-02-13),

4. 9809582 - Aminoester derivatives (2017-11-07),

5. 9763924 - Aminoester derivatives (2017-09-19),

6. 9636336 - Aminoester derivatives (2017-05-02),

7. 9597323 - Aminoester derivatives (2017-03-21),

8. 9326976 - Carbamate derivatives (2016-05-03),

9. 9212186 - Bicyclic pyrazole LRRK2 small molecule inhibitors (2015-12-15),

10. 9212173 - Pyrazole aminopyrimidine derivatives as LRRK2 modulators (2015-12-15),

11. 9199980 - Compounds (2015-12-01),

12. 9169245 - Inhibitors of PDE4 enzyme and antagonists of muscarinic M3 receptor (2015-10-27),

13. 9145409 - Benzhydryl derivatives (2015-09-29),

14. 9145402 - Aminopyrimidine derivatives as LRRK2 modulators (2015-09-29),

15. 9133185 - Heteroaryl derivatives (2015-09-15),

Title: Charles Baker-Glenn: Pioneering Inventor from Essex, GB

Introduction: Charles Baker-Glenn is a renowned inventor hailing from Essex, GB, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Charles Baker-Glenn holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices, showcasing his versatility and ingenuity in inventing cutting-edge solutions.

Career Highlights: With a career spanning over two decades, Charles Baker-Glenn has worked with leading tech companies and research institutions, spearheading projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Charles Baker-Glenn has collaborated with top scientists, engineers, and designers, fostering a culture of innovation and excellence that has led to the development of groundbreaking technologies with real-world applications.

Conclusion: Charles Baker-Glenn's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, has solidified his reputation as a visionary inventor whose work continues to inspire and shape the future of technology.